Frequently Asked Questions

What makes COLLIAGE collagen peptide unique for joint health? 
COLLIAGE is scientifically engineered using a proprietary enzymatic process that produces collagen peptides of approximately 3.5 kDa in length with a unique composition. This specific composition has been proven to be the most effective in supporting joint health, setting COLLIAGE apart from other collagen peptide products on the market.

How should I take COLLIAGE?
Incorporating COLLIAGE into your daily routine is simple. Just dissolve one sachet into your favorite beverage, whether it's water, smoothie, coffee, or tea. COLLIAGE is heat-stable, so it can be mixed with both hot and room temperature drinks.

Does COLLIAGE collagen peptide get absorbed by the body?
Contrary to popular belief, collagen peptides can survive the digestive process when taken orally. Multiple scientific studies have shown that collagen peptides can be absorbed intact and reach the target joint tissue, where they can work their magic.

  1. Oesser, S., Adam, M., Babel, W. & Seifert, J. J. Nutr. 129, 1891-1895 (1999).

How does COLLIAGE work to support joint health?
Once COLLIAGE is absorbed by the body, it reaches the target cells in the joints. There, it stimulates the joint cells, encouraging the growth of essential components that maintain joint health and function.

  1. Oesser, S. & Seifert, J. Cell Tissue Res. 311, 393-399 (2003).
  2. Schunck, M. & Oesser, S. J. Int. Soc. Sports Nutr. 10, P23 (2013).

How long does it take to see results with COLLIAGE?
Clinical studies suggest that daily consumption of COLLIAGE for at least 1-3 months yields the best results. (References below) Consistent use is key to experiencing the full benefits of this powerful collagen peptide formula.

Is COLLIAGE backed by scientific research?
Absolutely. Numerous laboratory and animal studies have demonstrated the effectiveness of COLLIAGE. The product has been shown to stimulate chondrocytes, the cells responsible for producing joint components crucial for maintaining joint health. In animal studies, COLLIAGE has been observed to accumulate in the joints after oral consumption and prevent the worsening of joint damage. 

  1. Dar, Q. A. et al., PLoS One 12, e0174705 (2017).
  2. Isaka, S. et al., Exp. Ther. Med. 13, 2699-2706 (2017).

Are there clinical studies that prove COLLIAGE's effectiveness?
Yes, multiple clinical studies have shown that COLLIAGE effectively reduces joint pain and improves function. Most studies report improvements in joint function and pain after 1-3 months of regular consumption, highlighting COLLIAGE's potential to regenerate joint components in patients. If you'd like to learn more, we can provide you with references to these studies.

  1. Benito-Ruiz, P. et al., Int. J. Food Sci. Nutr. 60 Suppl 2, 99-113 (2009).
  2. McAlindon, T. E. et al., Osteoarthritis Cartilage 19, 399-405 (2011).
  3. Clark, K. L. et al., Curr. Med. Res. Opin. 24, 1485-1496 (2008).
  4. Gonçalves, F. K., Int. J. Case Rep. Images 8, 364-369 (2017).
  5. Zdzieblik, D. et al., Appl. Physiol. Nutr. Metab. 42, 588-595 (2017).
  6. Zdzieblik, D. et al., Nutrients 13, 523 (2021).

Is COLLIAGE collagen peptide safe for long-term use?
Yes, COLLIAGE collagen peptide is safe for long-term use. Collagen peptides are classified as Generally Recognized as Safe (GRAS) by the U.S. Food and Drug Administration (FDA) for use in food products. This designation means that qualified experts consider the ingredient safe when used as intended.

Clinical evidence supports this safety profile. A study by Benito-Ruiz et al. (2009) demonstrated that a daily intake of 10 grams of collagen hydrolysate over six months was safe and well-tolerated. Furthermore, many of our customers have used COLLIAGE consistently for extended periods to support joint health, without reporting any adverse effects.

As with any supplement, individuals with specific health conditions or concerns should consult a healthcare professional before starting regular use.

  1. Benito-Ruiz, P. et al., Int. J. Food Sci. Nutr. 60 Suppl 2, 99-113 (2009).